Search tips
Search criteria 


Logo of skullbasesurgInstructions for AuthorsSubscribe to Skull BaseAbout Skull BaseEditorial BoardThieme Medical PublishingSkull Base An Interdisciplinary Approach ...
Skull base surgery. 1993 July; 3(3): 141–145.
PMCID: PMC1656440

Surgical Resection Followed by Brachytherapy for Malignancies Involving the Base of the Skull


Between January 1990 and July 1991, 14 patients were referred to the University of Pittsburgh for cranial base surgery following diagnosis of end-stage primary or recurrent neoplasms of the base of the skull. The treatment approach consisted of resection of the tumor along with placement of afterloading nylon catheters for iridium-192 implantation in areas where remaining tumor was believed to be present. A median dose of 3600 cGy (range, 2500 to 6000) was delivered to the tumor bed 1 to 14 days following surgery. with a median follow-up of 9 months, three patients remain alive without disease at 18, 19 and 36 months, and two are alive with disease at 5 and 31 months. Six patients died of disease at 3, 3, 3, 7, 16, and 17 months and three patients died of intercurrent disease at 1, 5, and 11 months. Cranial base surgery followed by brachytherapy appears to be a viable alternative in patients who otherwise have exhausted other methods of treatment. Careful attention to preoperative evaluation, surgery, and postoperative recovery should be given in order to prevent major complications.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Puthawala AA, Syed AM, Gates TC. Iridium-192 implants in the treatment of tonsillar region malignancies. Arch Otolaryngol. 1985 Dec;111(12):812–815. [PubMed]
  • Saw CB, Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):135–139. [PubMed]
  • Martinez A, Goffinet DR, Fee W, Goode R, Cox RS. 125Iodine implants as an adjuvant to surgery and external beam radiotherapy in the management of locally advanced head and neck cancer. Cancer. 1983 Mar 15;51(6):973–979. [PubMed]
  • Kumar PP, Patil AA, Leibrock LG, Chu WK, Syh J, McCaul GF, Reeves MA. Brachytherapy: a viable alternative in the management of basal meningiomas. Neurosurgery. 1991 Nov;29(5):676–680. [PubMed]
  • Kumar PP, Good RR, Skultety FM, Leibrock LG. Local control of recurrent clival and sacral chordoma after interstitial irradiation with iodine-125: new techniques for treatment of recurrent or unresectable chordomas. Neurosurgery. 1988 Mar;22(3):479–483. [PubMed]
  • Gutin PH, Leibel SA, Hosobuchi Y, Crumley RL, Edwards MS, Wilson CB, Lamb S, Weaver KA. Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. Neurosurgery. 1987 Jun;20(6):938–945. [PubMed]

Articles from Skull Base Surgery are provided here courtesy of Thieme Medical Publishers